Halozyme Therapeutics, Inc. (HALO)
NASDAQ·Healthcare·Biotechnology
$130.91
-0.10%
Mkt Cap $14.86B
Analyst Ratings
Buy
8
Hold
2
Sell
0
Price Target (27 analysts)
$103.00
Range $90.00 – $115.00
Implied Upside
-21.3%
Consensus $103.00 vs current $130.91